Neville Campbell, MD
Pain Medicine · Las Vegas, NVNPI 1487881249
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,648 of the $10,893 with a category attached, or 79.4%. It is spread thinly across 33 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,548 and has fallen 54.9% since, to $1,150 in 2025.
Across 241 payments — averaging $45.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$1K
- Painteq LLC$1K
- Spinal Simplicity, LLC$1K
- Medtronic$1K
- Nevro Corp.$615
- plus $3K from 27 others
Across 1 payment — averaging $410.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$410
What the payments were for
- Travel & lodging$1,91918%
- Food & beverage$8,64879%
- Education$3253%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 19 | $2,355 |
| Abbott | 52 | $1,397 |
| Painteq LLC | 8 | $1,270 |
| Spinal Simplicity, LLC | 17 | $1,125 |
| Medtronic(2 entities) | 37 | $1,117 |
| Nevro Corp. | 7 | $615 |
| Spinefrontier, Inc. | 5 | $596 |
| Vertiflex, Inc. | 5 | $511 |
| Stimwave Technologies Incorporated | 6 | $273 |
| Daiichi Sankyo Inc. | 15 | $171 |
| Relievant Medsystems, Inc. | 1 | $171 |
| Baudax Bio Inc. | 1 | $148 |
| Zyla Life Sciences, Inc. | 17 | $134 |
| Assertio Therapeutics, Inc. | 18 | $131 |
| Stryker | 1 | $127 |
| AbbVie(2 entities) | 6 | $110 |
| SPR Therapeutics, Inc | 1 | $103 |
| Vertos Medical, Inc. | 1 | $99 |
| Biotissue Holdings Inc. | 1 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Collegium Pharmaceutical, Inc. | 4 | $57 |
| Amgen | 2 | $37 |
| Lundbeck LLC | 1 | $33 |
| Nalu Medical, Inc. | 2 | $30 |
| Sentynl Therapeutics, Inc. | 2 | $27 |
| Averitas Pharma Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Novartis | 1 | $17 |
| GSK | 1 | $16 |
| Pfizer | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| MDD US Operations, LLC | 1 | $12 |
| Biodelivery Sciences International, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$2,132
- PAINTEQ$1,138
- HA MINUTEMAN G3-R$863
- InSpan$435
- SIJFuse$435
- FacetFuse$435
- NanoFuse$435
- Superion ISS$416
- PROCLAIM$370
- Omnia$252
- Senza$189
- MYSTIM$153
- INTELLIS ADAPTIVESTIM$150
- ANJESO$148
- EVEREST MI$127
- Senza Spinal Cord Stimulation System$122
- SPRINT PNS System$103
How this compares
$10,893 in reported general payments places this provider in the 80th percentile of 101 pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BotoxOnabotulinumtoxina | 15 | $18,568 |
| Gabapentin | 13 | $96 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieBotox | $110 | $18,56815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 101 pain medicine providers in Nevada.
Other pain medicine in Las Vegas
- Kunal ParikhLas Vegas$26K
- Nader HelmiLas Vegas$25K
- Sungkook ParkLas Vegas$20K
- Pouya MohajerLas Vegas$17K
- David AlvaradoLas Vegas$15K
- Okwuchukwu ObiLas Vegas$15K
- Christopher FisherLas Vegas$13K
- Andrew KimLas Vegas$11K
- Heerak KangLas Vegas$11K
- Ruben AlexanderLas Vegas$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.